Board approved issuance of Non-Convertible Debentures aggregating up to 585 Cr on private placement basis. NCDs will be unlisted; tenure, coupon, security to be disclosed at allotment. Fills the undecided debt leg for pending acquisition funding after equity funding was secured; debt structure was the open item behind the ongoing rating watch. Adds leverage while acquisition closes remain pending; coupon, tenure, security, use of proceeds and timeline undisclosed; final terms and rating outcome remain to be seen.
Gujarat Themis Biosyn Completes JPY 21.5 Billion MicroBiopharm Japan Acquisition
Gujarat Themis Biosyn Allots Rs 585 Crore NCDs To Fund MBJ Acquisition
Gujarat Themis Biosyn Board Approves ₹335 Crore Preferential Share Issue
Gujarat Themis Biosyn Closes ₹750 Crore QIP At ₹354 Per Share
Gujarat Themis Biosyn Opens QIP At ₹372.57 Floor Price